Shelter Pharma Share Price Today | Stock Price & Shelter Pharma Share Screener
Track the current Shelter Pharma share price and stock price live with TickJournal's free stock screener. Check SHELTER 52-week chart for the annual price range and momentum. Use the Shelter Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Shelter Pharma opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Shelter Pharma Share Price Chart
Track the current stock price of Shelter Pharma with an interactive chart. Analyse SHELTER share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Shelter Pharma stock quote in one place.
Shelter Pharma Company Profile - Fundamental Screener
Screen Shelter Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SHELTER shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE013V01011.
Company Details
Classification
Identifiers and Leadership
Shelter Pharma Balance Sheet Screener
Screen SHELTER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹84, up from ₹48 in 2025.
Latest statistics put total assets at ₹84 and shareholder funds at ₹77, with a leverage ratio of 0.02.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Assets |
|||||||
| Total Assets | 84 | 48 | 38 | 21 | 13 | 10 | 11 |
| Current Assets | 55 | 33 | 30 | 19 | 10 | 8 | 8 |
| Fixed Assets | 7 | 6 | 4 | 2 | 2 | 2 | 2 |
Liabilities |
|||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||
| Total Equity | 77 | 43 | 36 | 15 | 9 | 7 | 7 |
| Share Capital | 17 | 12 | 12 | 8 | 1 | 1 | 1 |
| Reserves & Surplus | 56 | 31 | 24 | 7 | 8 | 7 | 7 |
Shelter Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Shelter Pharma income statement and profit fundamentals. Analyze SHELTER quarterly results. Shelter Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹73 and net profit of ₹9.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||
| Revenue | 0 | 73 | 51 | 40 | 36 | 30 | 23 | 30 |
| Expenses | 0 | 60 | 41 | 32 | 28 | 27 | 22 | 30 |
Operating Costs and Margins | ||||||||
| EBITDA | 0 | 13 | 10 | 9 | 8 | 3 | 0 | 0 |
| Operating Profit % | 0.00% | 17.00% | 20.00% | 21.00% | 22.00% | 10.00% | 1.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | ||||||||
| Profit Before Tax | 0 | 12 | 10 | 8 | 7 | 3 | 0 | 0 |
| Tax | 0 | 3 | 2 | 2 | 2 | 1 | 0 | 0 |
| Net Profit | 0 | 9 | 7 | 6 | 5 | 2 | 0 | 0 |
| EPS | 0.00 | 6.57 | 6.26 | 5.36 | 6.72 | 42.54 | 0.88 | 1.77 |
Shelter Pharma Cash Flow Screener - Liquidity Fundamentals
Screen SHELTER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹13, and net cash flow was an outflow of ₹2.
Over the same period, investing activities used ₹15 and financing activities provided ₹25.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2017-March |
|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||
| Operating Activities | -13 | 5 | -2 | 0 | 1 | 0 | 0 | 0 |
| Investing Activities | -15 | -7 | -4 | 0 | -1 | 0 | 0 | 0 |
Financing and Net Cash | ||||||||
| Financing Activities | 25 | 0 | 11 | 0 | 0 | 1 | 0 | 0 |
| Net Cash Flow | -2 | -2 | 5 | 0 | 0 | 0 | 0 | 0 |
Shelter Pharma Shareholding Pattern Screener
See Shelter Pharma shareholding pattern with promoter, FII, and DII holdings. Check Shelter Pharma promoter holding and ownership changes for SHELTER on TickJournal, and see how institutional stock price moves affect the market.
In 2026-May, promoters held 44.38%, foreign institutions 0.00%, domestic institutions 0.00% and the public 51.46%, spread across 1,076 shareholders.
The shareholder count was 1,076 in 2026-May, compared with 1,071 in 2026-Mar.
| Item | 2026-May | 2026-Mar | 2025-Nov | 2025-Oct | 2025-Sept | 2025-Aug | 2025-Mar | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 44.38% | 44.38% | 47.19% | 46.98% | 52.32% | 52.32% | 52.32% | 54.97% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 51.46% | 51.46% | 49.32% | 48.66% | 42.82% | 42.69% | 43.24% | 40.12% |
| Other Holding | 4.16% | 4.16% | 3.49% | 4.36% | 4.86% | 4.99% | 4.44% | 4.91% |
| Shareholder Count | 1,076 | 1,071 | 1,093 | 1,094 | 1,094 | 1,109 | 1,153 | 1,119 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Shelter Pharma. Shelter Pharma dividend yield can be compared with peers and other stocks in the market.
Shelter Pharma Stock Index Membership - Nifty & Sensex
See which indices include Shelter Pharma stock. Check SHELTER index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Shelter Pharma Market Events Screener - Corporate Actions
Get Shelter Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Shelter Pharma stock events that may affect SHELTER share price, along with derivatives, futures and options activity and sector gainers.
10 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.
It is followed by Quarterly Result Announcement dated May 28, 2026 and Quarterly Result Announcement dated November 10, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | 18.41% |
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | -3.23% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 0.87% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -2.22% |
| 2025-09-23 | 2025-09-23 | Dividend | ₹ 0.35 /share | -3.84% |
| 2025-07-23 | 2025-07-23 | Extraordinary General Meeting | NA | 11.04% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 3.95% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | 0.58% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 1.13% |
| 2024-09-23 | 2024-09-23 | Dividend | ₹ 0.33 /share | 2.64% |
Shelter Pharma Competitors Screener - Peer Stocks Comparison
Screen SHELTER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 447,476 | 36.44 | 61,674 | 12.69% | 11,565 | 47.42 |
| Divis Laboratories | 250,363 | 86.51 | 11,067 | 13.95% | 2,568 | 58.71 |
| Torrent Pharmaceuticals | 186,152 | 85.91 | 13,886 | 20.34% | 2,138 | 48.14 |
| Zydus Life Science | 120,798 | 26.32 | 27,658 | 17.64% | 5,026 | 61.81 |
| Cipla | 111,426 | 33.44 | 29,045 | 2.24% | 3,870 | 44.03 |
| Laurus Labs | 106,838 | 99.70 | 6,868 | 22.01% | 890 | 58.00 |
| Mankind Pharma | 105,107 | 48.73 | 14,636 | 14.85% | 1,938 | 64.24 |
| Dr Reddys Laboratories | 104,492 | 32.05 | 35,059 | 3.90% | 4,158 | 69.59 |
| Aurobindo Pharma | 97,682 | 26.36 | 34,145 | 5.56% | 3,503 | 54.69 |
| Lupin | 93,829 | 16.99 | 29,039 | 26.75% | 5,356 | 34.02 |
Shelter Pharma Company Announcements - News & Reports Screener
Screen SHELTER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated and .
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Change in Management | - | |
| Shareholder Meeting / Postal Ballot-Scrutinizers Report | - | |
| Shareholder Meeting / Postal Ballot-Outcome of AGM | - | |
| 2026-10-02 | Closure of Trading Window | - |
| 2026-09-30 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Positive DoctorS Review And Feedback On Company Products. | - |
| 2026-09-29 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-09-18 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 -Participation In Vishwa Ayurveda Parishad Exhibition | - |
| 2026-09-07 | Newspaper Advertisement - Notice To The Members Of The Company Regarding 19Th Annual General Meeting To Be Held At The Registered Office Of The Company On Tuesday 29Th September 2026 | - |
| 2026-09-04 | Notice Of AGM - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-09-04 | Reg. 34 (1) Annual Report. | - |
| 2026-09-01 | Intimation Of The Cut-Off Date For The AGM Of The Company "Shelter Pharma Limited" | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-01 | Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On The Tuesday 01ST September 2026 At 01.45 PM. | - |
| 2026-08-25 | Intimation Under Regulation 30 Of SEBI LODR (Regulation)- 2015 Completion And Commencement Of Dispatch Of Export Order | - |
| 2026-08-24 | Intimation Under Regulation 30 Of SEBI LODR (Regulation)- 2015 Completion And Commencement Of Dispatch Of Export Order | - |
| 2026-08-21 | Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - New Product Launch. | - |
| 2026-08-20 | Intimation Under Regulation 30 Of SEBI LODR (Regulation)- 2015 Completion And Commencement Of Dispatch Of Export Order | - |
| 2026-08-10 | Intimation Under Regulation 30 Of SEBI LODR (Regulation) 2015- Completion And Commencement Of Dispatch Of Export Order | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-07-31 | Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On 31St July 2026 | - |
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 0.86. Market capitalisation stands at ₹59.26 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 7 balance sheet periods, 8 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.